Showing results (191-200 of 290) with videos related to
Sort By:
Pageof 29
Nature Medicine|May 25, 2010
Missing pieces in the Parkinson's disease puzzleJose A Obeso, Maria C Rodriguez-Oroz, Christopher G Goetz, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 11, 2017
Systematic review of severity scales and screening instruments for tics: Critique and recommendationsDavide Martino, Tamara M Pringsheim, Andrea E Cavanna, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 24, 2010
Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendationsCarlo Colosimo, Pablo Martínez-Martín, Giovanni Fabbrini, et al.Movement Disorders Clinical Practice|October 27, 2018
Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and RecommendationsTiago A Mestre, Maria João Forjaz, Philipp Mahlknecht, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 9, 2010
Scales to assess sleep impairment in Parkinson's disease: critique and recommendationsBirgit Högl, Isabelle Arnulf, Cynthia Comella, et al.Annals of Neurology|January 5, 2022
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation CarriersGian Pal, Graziella Mangone, Emily J Hill, et al.Neurobiology of Disease|June 2, 2022
Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment statusRobin M Voigt, Zeneng Wang, J Mark Brown, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 30, 2008
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventionsChristopher G Goetz, Joanne Wuu, Michael P McDermott, et al.Movement Disorders : Official Journal of the Movement Disorder Society|February 11, 2009
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's diseaseMarian L Evatt, K Ray Chaudhuri, Kelvin L Chou, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 24, 2016
A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's DiseaseFrançois Tison, Charlotte Keywood, Mark Wakefield, et al.Pageof 29